Impact Net Receivables from 2010 to 2026
| IBO Stock | USD 0.45 0.03 6.25% |
Net Receivables | First Reported 2017-06-30 | Previous Quarter 200 K | Current Value 214 K | Quarterly Volatility 123.2 K |
Check Impact BioMedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Impact BioMedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 660 K, Selling General Administrative of 1 M or Other Operating Expenses of 2.1 M, as well as many indicators such as Price To Sales Ratio of 20.78, Dividend Yield of 0.0 or PTB Ratio of 11.38. Impact financial statements analysis is a perfect complement when working with Impact BioMedical Valuation or Volatility modules.
Impact | Net Receivables | Build AI portfolio with Impact Stock |
Evaluating Impact BioMedical's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Impact BioMedical's fundamental strength.
Latest Impact BioMedical's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Impact BioMedical over the last few years. It is Impact BioMedical's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Impact BioMedical's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Impact Net Receivables Regression Statistics
| Arithmetic Mean | 68,616 | |
| Geometric Mean | 10,019 | |
| Coefficient Of Variation | 151.51 | |
| Mean Deviation | 84,611 | |
| Median | 14,063 | |
| Standard Deviation | 103,963 | |
| Sample Variance | 10.8B | |
| Range | 330.1K | |
| R-Value | 0.77 | |
| Mean Square Error | 4.8B | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | 15,753 | |
| Total Sum of Squares | 172.9B |
Impact Net Receivables History
About Impact BioMedical Financial Statements
Impact BioMedical investors utilize fundamental indicators, such as Net Receivables, to predict how Impact Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 211.6 K | 222.2 K |
Pair Trading with Impact BioMedical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical will appreciate offsetting losses from the drop in the long position's value.Moving against Impact Stock
The ability to find closely correlated positions to Impact BioMedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical to buy it.
The correlation of Impact BioMedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Impact BioMedical Correlation against competitors. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Will Biotechnology sector continue expanding? Could Impact diversify its offerings? Factors like these will boost the valuation of Impact BioMedical. Market participants price Impact higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Impact BioMedical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Impact BioMedical's market price often diverges from its book value, the accounting figure shown on Impact's balance sheet. Smart investors calculate Impact BioMedical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Impact BioMedical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.